NorthWest Biotherapeutics Inc (NWBO)

[koman]

FATCAT, looks like you are fairly new in iHUB. I used to post on this board but left NWBO bec I'm very bearish on this technology, but I'd like to be proven wrong as a learning experience. I have been expecting the first interim analysis by end of Jan 2014 to be a simple continue. Prolonged interim analysis to me is not a good sign. If the data was extremely good based on 66events, it would be halted or simply continued to the next event. If there is some potential for separation of efficacy then it will be continued to see if the separation continues. BUT if there is no difference, they may wait for further events for confirmation before advising halt to the trial. Also, I'm having doubts that NWBO will meet their target date for completion of enrollment for pIII GBM trial and expect them to delay again the anticipated completion date (another bad sign). But that will be moot point considering that this binary event may be the key pivotal event coming up that will shoot the pps up/down dramatically. I'm not trying to scare anyone out of their shares because I don't know what the future holds, but I'm giving reason for my doubts and believe that if I'm wrong there is always an entry point on the upside because this will be a paradigm shift against the current belief that cancer vaccines don't work (or work well enough) (DNDN and GALE are in this category which I won't talk about now) because of immune checkpoints like PD-1. GL if you have the balls to be in this one. I'm on the sidelines on this one.